LYUMJEV® ▼ (insulin lispro) is indicated for the treatment of diabetes mellitus in adults. Lyumjev is a mealtime insulin for subcutaneous injection and should be administered zero to two minutes before the start of the meal, with the option to administer up to 20 minutes after starting the meal.

Lyumjev is not indicated for use in children.

We have a Practical Guide that will support you prepare and initiate the Lilly KwikPen® step by step


Lyumjev is a mealtime insulin. The dose regimen (dose and timing) should be adjusted according to the needs of the individual patient.

If moving from Humalog to Lyumjev, please use unit for unit dosing *1.


Onset of action of Lyumjev was 20 minutes post dose (11 minutes faster than Humalog). During the first 30 minutes post dose, Lyumjev had a 3‑fold greater glucose-lowering effect compared to Humalog. Maximum glucose‑lowering effect occurred between 1 and 3 hours after injection.The late insulin action, from 4 hours until the end of the glucose clamp, was 54 % lower with Lyumjev than observed with Humalog. The duration of action of Lyumjev was 5 hours, 44 minutes shorter *2

Quick overview of Insulins


Upcoming Lilly Webinars

click here

2x-hero-group-of-people-working-together-in-front-of-window-19017-0201 smaller.jpg

Educational Videos

click here


Sign up for Updates

click here

For more information and ordering of material & demo devices

Lyumjev is available as :

  • 5 x 3 ml Lyumjev KwikPen 100 units/ml

  • 1 x 10 ml Lyumjev Vial 100 units/ml

  • 5 x 3 ml Lyumjev Cartridge 100 units/ml

  • 5 x 3 ml Lyumjev Junior KwikPen 100 units/ml

  • 5 x 3 ml Lyumjev KwikPen 200 units/ml

(1) Lyumjev SPC, avsnitt 4.2, 11.02.2021

(2) Lyumjev SPC, avsnitt 5.1, 11.02.2021

PP-UR-NO-0004 06.2021